However, a study in head and neck squamous cell carcinoma described a characteristic promoter methylation pattern of ZNF10, TMPRSS12, ERGIC2, and RNF215 genes, which was proposed as a biomarker of response to radiotherapy treatment (33). Here, TMPRSS12 is linked to head and neck squamous cell carcinoma.